News | October 07, 2009

Incidental Findings in Cardiac CT Rarely Significant

October 7, 2009 – Rates of death were similar in patients with and without incidental findings (IF) identified with cardiac computed tomography (CT), and IF was not an independent predictor of noncardiac death, reported researchers in a study published in the online version of the October 2009 issues of the Journal of the American College of Cardiology.

As cardiac CT becomes more widely adopted, prompting the discovery of extracardiac IF to potentially increase, researchers in the study, Potential Clinical and Economic Consequences of Noncardiac Incidental Findings on Cardiac Computed Tomography, set out to determine “the incidence, clinical significance, and potential financial impact of noncardiac IF identified with cardiac computed tomography (CT).”

Of 966 patients (58 ± 16 years of age, 55.4 percent men, >98 percent outpatients), who underwent cardiac CT and had noncardiac structures evaluated after full field of view (32 to 50 cm) reconstruction, 401 (41.5 percent) patients had noncardiac IF. A total of 12 (1.2 percent) patients had clinically significant (CS) findings, and 68 (7.0 percent) patients had indeterminate findings. At follow-up (18.4 ± 7.6 months), none of the indeterminate findings became CS. After adjusting for age, IF were not an independent predictor of noncardiac death. Noncardiac death and cancer death in patients with and without IF were not statistically different. One patient suffered a major complication related to the investigation of an IF. The total direct cost associated with investigating IF was Canadian $57,596 (U.S. $83,035).

Based on their findings, the researchers concluded: “Although noncardiac IF are common, clinically significant or indeterminate IF are less prevalent. Rates of death were similar in patients with and without IF, and IF was not an independent predictor of noncardiac death. The investigation of IF is not without cost or risk. Larger studies are required to assess the potential mortality benefit of identifying IF.”

References: JMacHaalany, M.D., Jimmy, et al. Potential Clinical and Economic Consequences of Noncardiac Incidental Findings on Cardiac Computed Tomography. J Am Coll Cardiol, 2009; 54:1533-1541, doi:10.1016/j.jacc.2009.06.026.

For more information: http://content.onlinejacc.org/cgi/content/abstract/54/16/1533

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | Computed Tomography (CT) | August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer
News | Lung Cancer | August 02, 2017
To raise public awareness of lung cancer—the leading cancer killer of men and women—the American Lung Association's...
GE’s DoseWatch is a digital informatics solution that automatically collects, monitors and reports on radiation dose indices for diagnostic imaging exams
News | Radiation Dose Management | July 31, 2017
GE Healthcare announced that it has licensed computed tomography (CT) organ dosimetry technology developed at Duke...
Contrast Media from Bayer, trends in contrast media and developments in contrast media
Feature | Contrast Media | July 28, 2017 | By Dave Fornell
Here are several updates in medical imaging ...
New York Hospital Finds Significant Cost Savings With Toshiba’s Aquilion One CT
News | Computed Tomography (CT) | July 25, 2017
In five years, Kaleida Health’s Stroke Care Center (SCC) at the Gates Vascular Institute in Buffalo, N.Y., has realized...
Samsung Introduces FDA-Cleared BodyTom Elite CT Scanner
Technology | Computed Tomography (CT) | July 24, 2017
Samsung announced U.S. Food and Drug Administration (FDA) approval of the BodyTom Elite, an upgraded version of its...
Sponsored Content | Videos | CT Angiography (CTA) | July 21, 2017
DAIC and ITN Editor Dave Fornell discusses some of the most innovative new computed tomography (CT) technology and tr
ACR Updates Radiation Oncology and Medical Physics Guidance With ASTRO and AAPM
News | Radiation Dose Management | July 19, 2017
July 19, 2017 — The American College of Radiology (ACR) recently collaborated with professional medical societies to
Sponsored Content | Videos | CT Angiography (CTA) | July 19, 2017
Matthew Budoff, M.D., FACC, professor of medicine, David Geffen School of Medicine at UCLA, endowed chair of preventi
Overlay Init